Skip to main content

1 article related to "Enavatuzumab"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 08 Jan 2014

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR

in Inflammation

James W. Purcell
Han K. Kim
Sonia G. Tanlimco
Minhtam Doan
Melvin Fox
Peter Lambert
Debra T. Chao
Mien Sho
Keith E. Wilson
Gary C. Starling

Frontiers in Immunology

doi 10.3389/fimmu.2013.00505

6,940 views
15 citations